Skip to content
GLP-1 Scorecard
Menu
Site position #105

HealthSource

Published by GLP-1 ScorecardUpdated

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

Visit HealthSourceWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$199/mo (all doses, compounded)
Tirzepatide
$299/mo (all doses, compounded)
Coverage
All 50 states
Brand-name
Not confirmed

Weigh HealthSource against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value66/100
Dose & formulation83/100
Clinical oversight80/100
Labs & monitoring54/100
Fulfillment80/100
Contract terms55/100

Strengths

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

What to consider

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical

Bottom line — Grade C

Best for: Shoppers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

Site position #105 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest HealthSource — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect HealthSource's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on HealthSource's site. Not medical advice; see our disclosure.

← Back to the scorecard